SCHEMBL31438003

SCHEMBL31438003

COC(=O)c1cc2c(ccn2C2CCC2)cc1OC

nearest known ligand 0.43

Predicted protein targets (top 20)

geneUniProtsupporting neighboursconfidence
FGFR1 P11362 1/20 0.43
SRC P12931 1/20 0.43
RAB9A P51151 1/20 0.40
L3MBTL1 Q9Y468 1/20 0.40
KDM2B Q8NHM5 3/20 0.39
TFPI2 P48307 1/20 0.38
GAA P10253 1/20 0.38
DRD2 P14416 2/20 0.38
DRD4 P21917 2/20 0.38
KDM4E B2RXH2 1/20 0.36
ALDH1A1 P00352 1/20 0.36
MAPT P10636 1/20 0.36
TSHR P16473 1/20 0.36
HSD17B10 Q99714 1/20 0.36
IDH1 O75874 1/20 0.36
MEN1 O00255 1/20 0.36
KMT2A Q03164 1/20 0.36
HTR1A P08908 1/20 0.36
HTR1D P28221 1/20 0.36
HTR1B P28222 1/20 0.36

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL21712228 0.77 TUBB4A (0.49) FGFR1SRCRAB9AL3MBTL1GAA
SCHEMBL15970928 0.75 ALDH1A1 (0.51) FGFR1RAB9AL3MBTL1GAAKDM4E
SCHEMBL28834819 0.75 ALDH1A1 (0.44) RAB9AGAAKDM4EALDH1A1MAPT
SCHEMBL27519949 0.74 ALDH1A1 (0.53) RAB9AL3MBTL1GAAKDM4EALDH1A1
SCHEMBL2596068 0.72 OPRK1 (0.42) GAAALDH1A1
SCHEMBL28834792 0.72 SIRT6 (0.42) GAAALDH1A1MAPTMEN1KMT2A
SCHEMBL26123802 0.72 ALDH1A1 (0.54) RAB9AGAAKDM4EALDH1A1MAPT
SCHEMBL14337885 0.72 TUBB4A (0.49) FGFR1SRCRAB9AL3MBTL1GAA
SCHEMBL30480626 0.69 IRAK4 (0.36) TFPI2IDH1
SCHEMBL28849350 0.68 KDM4E (0.42) FGFR1RAB9AGAAKDM4EALDH1A1

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 2 patents. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
EP-4741383-A1 COMPOUND AND USE THEREOF AS ANTI-CANCER DRUG Tyligand Bioscience (Shanghai) Limited (CN) 2026-05-13 EP disclosed
WO-2025011480-A1 COMPOUND AND USE THEREOF AS ANTI-CANCER DRUG 泰励生物科技(上海)有限公司 2025-01-16 WO disclosed